MEDICATIONS References

1.            Bliwise DL. Sleep disorders in Alzheimer's disease and other dementias. Clin Cornerstone 6 Suppl 1A: S16-28, 2004.

2.            Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2: 182-187, 2002.

3.            Gagliardi L, and Wittert G. Management of obesity in patients with type 2 diabetes mellitus. Curr Diabetes Rev 3: 95-101, 2007.

4.            Greener MJ, and Guest JF. Do antidepressants reduce the burden imposed by depression on employers? CNS Drugs 19: 253-264, 2005.

5.            Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, and Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 36: 1577-1589, 2002.

6.            Happe S. Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Drugs 63: 2725-2737, 2003.

7.            Hollenberg NK. Considerations for management of fluid dynamic issues associated with thiazolidinediones. Am J Med 115 Suppl 8A: 111S-115S, 2003.

8.            Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, and Chen NH. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Sleep Med 8: 18-30, 2007.

9.            Labbate LA, Croft HA, and Oleshansky MA. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry 64 Suppl 10: 11-19, 2003.

10.       Leslie WS, Hankey CR, and Lean ME. Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review. QJM 100: 395-404, 2007.

11.            Moulik PK, and Hardy KJ. Hypertension, anti-hypertensive drug therapy and erectile dysfunction in diabetes. Diabet Med 20: 290-293, 2003.

12.            Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, Valagussa F, and Marchioli R. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet 370: 667-675, 2007.

13.       Ness-Abramof R, and Apovian CM. Drug-induced weight gain. Drugs Today (Barc) 41: 547-555, 2005.

14.            Papatsoris AG, and Korantzopoulos PG. Hypertension, antihypertensive therapy, and erectile dysfunction. Angiology 57: 47-52, 2006.

15.       Patel C, Wyne KL, and McGuire DK. Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence? Diab Vasc Dis Res 2: 61-66, 2005.

16.       Pijl H, and Meinders AE. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 14: 329-342, 1996.

17.            Williams K, and Reynolds MF. Sexual dysfunction in major depression. CNS Spectr 11: 19-23, 2006.

18.            Wofford MR, and King DS. Relationship between antihypertensive drugs and metabolic syndrome. Metab Syndr Relat Disord 2: 308-314, 2004.